Cassava Sciences, Inc.
SAVA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $109,336 | $135,021 | $169,652 | $245,887 |
| - Cash | $128,574 | $121,136 | $201,015 | $233,437 |
| + Debt | $0 | $0 | $139 | $236 |
| Enterprise Value | -$19,238 | $13,885 | -$31,224 | $12,686 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$89,423 | -$68,032 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$141,146 | -$104,427 | -$78,719 | -$32,334 |
| % Margin | – | – | – | – |
| Net Income | -$24,342 | -$97,217 | -$76,246 | -$32,385 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.52 | -2.32 | -1.8 | -0.81 |
| % Growth | 77.6% | -28.9% | -122.2% | – |
| Operating Cash Flow | -$116,929 | -$82,025 | -$77,514 | -$30,196 |
| Capital Expenditures | -$103 | -$414 | -$2,712 | -$22,214 |
| Free Cash Flow | -$117,032 | -$82,439 | -$80,226 | -$52,410 |